Skip to main content
. 2014 Dec 12;14:941. doi: 10.1186/1471-2407-14-941

Table 1.

Patient characteristics n = 75 patients

Age (avg ± SD) 64 ± 19
Grade I 6
II 22
III 30
NA 17
Lymph node status Pos 47
Neg 25
NA 3
ER Pos 44
Neg 31
PgR Pos 32
Neg 43
HER-2/neu Pos 30
Neg 45
TNBC 20
TPBC 11

NA: not available, ER: estrogen receptor, PgR: progesterone receptor, HER-2/neu: human epidermal growth factor receptor-2, TNBC: triple negative breast cancer, TPBC: triple positive breast cancer.